nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP2B6—malignant glioma	0.366	0.54	CbGaD
Modafinil—SLC6A3—malignant glioma	0.312	0.46	CbGaD
Modafinil—CYP1A2—Carmustine—malignant glioma	0.0998	0.569	CbGbCtD
Modafinil—CYP3A4—Temozolomide—malignant glioma	0.0754	0.43	CbGbCtD
Modafinil—Anxiety depression—Temozolomide—malignant glioma	0.00587	0.0604	CcSEcCtD
Modafinil—Condition aggravated—Temozolomide—malignant glioma	0.00528	0.0543	CcSEcCtD
Modafinil—Hyperacusis—Temozolomide—malignant glioma	0.00259	0.0266	CcSEcCtD
Modafinil—Personality disorder—Carmustine—malignant glioma	0.00231	0.0237	CcSEcCtD
Modafinil—Myasthenia—Carmustine—malignant glioma	0.00159	0.0163	CcSEcCtD
Modafinil—Tooth disorder—Temozolomide—malignant glioma	0.00149	0.0153	CcSEcCtD
Modafinil—Lung disorder—Temozolomide—malignant glioma	0.00136	0.014	CcSEcCtD
Modafinil—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00117	0.012	CcSEcCtD
Modafinil—Accidental injury—Carmustine—malignant glioma	0.00113	0.0116	CcSEcCtD
Modafinil—Disturbance in attention—Temozolomide—malignant glioma	0.00111	0.0114	CcSEcCtD
Modafinil—Thinking abnormal—Carmustine—malignant glioma	0.00109	0.0112	CcSEcCtD
Modafinil—Viral infection—Temozolomide—malignant glioma	0.00107	0.011	CcSEcCtD
Modafinil—Leukocytosis—Carmustine—malignant glioma	0.00106	0.0109	CcSEcCtD
Modafinil—Herpes simplex—Temozolomide—malignant glioma	0.00105	0.0108	CcSEcCtD
Modafinil—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00102	0.0105	CcSEcCtD
Modafinil—Hearing impaired—Temozolomide—malignant glioma	0.00101	0.0104	CcSEcCtD
Modafinil—Neck pain—Carmustine—malignant glioma	0.00101	0.0104	CcSEcCtD
Modafinil—Influenza like illness—Temozolomide—malignant glioma	0.000936	0.00963	CcSEcCtD
Modafinil—Abnormal vision—Carmustine—malignant glioma	0.00087	0.00894	CcSEcCtD
Modafinil—Mental disability—Carmustine—malignant glioma	0.000866	0.0089	CcSEcCtD
Modafinil—Abnormal vision—Temozolomide—malignant glioma	0.000841	0.00864	CcSEcCtD
Modafinil—Mental disability—Temozolomide—malignant glioma	0.000836	0.0086	CcSEcCtD
Modafinil—Ear pain—Temozolomide—malignant glioma	0.00082	0.00843	CcSEcCtD
Modafinil—Eye pain—Carmustine—malignant glioma	0.000802	0.00825	CcSEcCtD
Modafinil—Gastroenteritis—Temozolomide—malignant glioma	0.000789	0.00812	CcSEcCtD
Modafinil—Injury—Carmustine—malignant glioma	0.000788	0.0081	CcSEcCtD
Modafinil—Eye pain—Temozolomide—malignant glioma	0.000775	0.00797	CcSEcCtD
Modafinil—Amnesia—Carmustine—malignant glioma	0.000771	0.00792	CcSEcCtD
Modafinil—Amnesia—Temozolomide—malignant glioma	0.000745	0.00766	CcSEcCtD
Modafinil—Thirst—Temozolomide—malignant glioma	0.000735	0.00756	CcSEcCtD
Modafinil—Affect lability—Temozolomide—malignant glioma	0.000689	0.00708	CcSEcCtD
Modafinil—Ataxia—Carmustine—malignant glioma	0.000681	0.007	CcSEcCtD
Modafinil—Mood swings—Temozolomide—malignant glioma	0.000663	0.00682	CcSEcCtD
Modafinil—Ataxia—Temozolomide—malignant glioma	0.000658	0.00676	CcSEcCtD
Modafinil—Dry skin—Temozolomide—malignant glioma	0.000641	0.00659	CcSEcCtD
Modafinil—Muscular weakness—Carmustine—malignant glioma	0.000639	0.00657	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00063	0.00648	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00063	0.00648	CcSEcCtD
Modafinil—Muscular weakness—Temozolomide—malignant glioma	0.000617	0.00635	CcSEcCtD
Modafinil—Pancytopenia—Carmustine—malignant glioma	0.000594	0.00611	CcSEcCtD
Modafinil—Bronchitis—Temozolomide—malignant glioma	0.000582	0.00598	CcSEcCtD
Modafinil—Pancytopenia—Temozolomide—malignant glioma	0.000574	0.00591	CcSEcCtD
Modafinil—Hyperglycaemia—Carmustine—malignant glioma	0.000565	0.0058	CcSEcCtD
Modafinil—Pneumonia—Carmustine—malignant glioma	0.000561	0.00577	CcSEcCtD
Modafinil—Pollakiuria—Temozolomide—malignant glioma	0.000559	0.00574	CcSEcCtD
Modafinil—Erectile dysfunction—Temozolomide—malignant glioma	0.000557	0.00573	CcSEcCtD
Modafinil—Depression—Carmustine—malignant glioma	0.000556	0.00572	CcSEcCtD
Modafinil—Photosensitivity reaction—Temozolomide—malignant glioma	0.000552	0.00568	CcSEcCtD
Modafinil—Weight increased—Temozolomide—malignant glioma	0.00055	0.00566	CcSEcCtD
Modafinil—Weight decreased—Temozolomide—malignant glioma	0.000547	0.00563	CcSEcCtD
Modafinil—Hyperglycaemia—Temozolomide—malignant glioma	0.000546	0.00561	CcSEcCtD
Modafinil—Stomatitis—Carmustine—malignant glioma	0.000544	0.00559	CcSEcCtD
Modafinil—Urinary tract infection—Carmustine—malignant glioma	0.000542	0.00558	CcSEcCtD
Modafinil—Pneumonia—Temozolomide—malignant glioma	0.000542	0.00558	CcSEcCtD
Modafinil—Depression—Temozolomide—malignant glioma	0.000538	0.00553	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000535	0.0055	CcSEcCtD
Modafinil—Stomatitis—Temozolomide—malignant glioma	0.000526	0.0054	CcSEcCtD
Modafinil—Urinary tract infection—Temozolomide—malignant glioma	0.000524	0.00539	CcSEcCtD
Modafinil—Sinusitis—Temozolomide—malignant glioma	0.000506	0.0052	CcSEcCtD
Modafinil—Hallucination—Carmustine—malignant glioma	0.000498	0.00512	CcSEcCtD
Modafinil—Oedema peripheral—Carmustine—malignant glioma	0.000493	0.00507	CcSEcCtD
Modafinil—Connective tissue disorder—Carmustine—malignant glioma	0.000492	0.00506	CcSEcCtD
Modafinil—Visual impairment—Carmustine—malignant glioma	0.000483	0.00496	CcSEcCtD
Modafinil—Hallucination—Temozolomide—malignant glioma	0.000482	0.00495	CcSEcCtD
Modafinil—Pharyngitis—Temozolomide—malignant glioma	0.00048	0.00494	CcSEcCtD
Modafinil—Urinary tract disorder—Temozolomide—malignant glioma	0.000478	0.00492	CcSEcCtD
Modafinil—Oedema peripheral—Temozolomide—malignant glioma	0.000477	0.0049	CcSEcCtD
Modafinil—Benzphetamine—POR—malignant glioma	0.000476	0.0798	CrCbGaD
Modafinil—Connective tissue disorder—Temozolomide—malignant glioma	0.000476	0.00489	CcSEcCtD
Modafinil—Urethral disorder—Temozolomide—malignant glioma	0.000475	0.00488	CcSEcCtD
Modafinil—Visual impairment—Temozolomide—malignant glioma	0.000466	0.0048	CcSEcCtD
Modafinil—Erythema multiforme—Temozolomide—malignant glioma	0.000458	0.00471	CcSEcCtD
Modafinil—Cardiac disorder—Temozolomide—malignant glioma	0.000449	0.00462	CcSEcCtD
Modafinil—Arrhythmia—Carmustine—malignant glioma	0.000447	0.0046	CcSEcCtD
Modafinil—Angiopathy—Temozolomide—malignant glioma	0.000439	0.00452	CcSEcCtD
Modafinil—Mental disorder—Carmustine—malignant glioma	0.000439	0.00451	CcSEcCtD
Modafinil—Immune system disorder—Temozolomide—malignant glioma	0.000437	0.0045	CcSEcCtD
Modafinil—Mediastinal disorder—Temozolomide—malignant glioma	0.000436	0.00449	CcSEcCtD
Modafinil—Malnutrition—Carmustine—malignant glioma	0.000436	0.00448	CcSEcCtD
Modafinil—Chills—Temozolomide—malignant glioma	0.000434	0.00447	CcSEcCtD
Modafinil—Mental disorder—Temozolomide—malignant glioma	0.000424	0.00436	CcSEcCtD
Modafinil—Back pain—Carmustine—malignant glioma	0.000422	0.00434	CcSEcCtD
Modafinil—Malnutrition—Temozolomide—malignant glioma	0.000421	0.00433	CcSEcCtD
Modafinil—Dysgeusia—Temozolomide—malignant glioma	0.000413	0.00424	CcSEcCtD
Modafinil—Tremor—Carmustine—malignant glioma	0.000409	0.0042	CcSEcCtD
Modafinil—Back pain—Temozolomide—malignant glioma	0.000408	0.00419	CcSEcCtD
Modafinil—Anaemia—Carmustine—malignant glioma	0.000403	0.00414	CcSEcCtD
Modafinil—Agitation—Carmustine—malignant glioma	0.000401	0.00412	CcSEcCtD
Modafinil—Tremor—Temozolomide—malignant glioma	0.000395	0.00406	CcSEcCtD
Modafinil—Fosphenytoin—CYP2B6—malignant glioma	0.000394	0.066	CrCbGaD
Modafinil—Ill-defined disorder—Temozolomide—malignant glioma	0.000391	0.00402	CcSEcCtD
Modafinil—Anaemia—Temozolomide—malignant glioma	0.000389	0.004	CcSEcCtD
Modafinil—Agitation—Temozolomide—malignant glioma	0.000387	0.00398	CcSEcCtD
Modafinil—Angioedema—Temozolomide—malignant glioma	0.000385	0.00396	CcSEcCtD
Modafinil—Malaise—Temozolomide—malignant glioma	0.00038	0.00391	CcSEcCtD
Modafinil—Vertigo—Temozolomide—malignant glioma	0.000379	0.00389	CcSEcCtD
Modafinil—Convulsion—Carmustine—malignant glioma	0.000378	0.00388	CcSEcCtD
Modafinil—Hypertension—Carmustine—malignant glioma	0.000376	0.00387	CcSEcCtD
Modafinil—Palpitations—Temozolomide—malignant glioma	0.000372	0.00383	CcSEcCtD
Modafinil—Chest pain—Carmustine—malignant glioma	0.000371	0.00382	CcSEcCtD
Modafinil—Myalgia—Carmustine—malignant glioma	0.000371	0.00382	CcSEcCtD
Modafinil—Anxiety—Carmustine—malignant glioma	0.00037	0.0038	CcSEcCtD
Modafinil—Cough—Temozolomide—malignant glioma	0.000368	0.00378	CcSEcCtD
Modafinil—Convulsion—Temozolomide—malignant glioma	0.000365	0.00375	CcSEcCtD
Modafinil—Hypertension—Temozolomide—malignant glioma	0.000364	0.00374	CcSEcCtD
Modafinil—Confusional state—Carmustine—malignant glioma	0.000359	0.00369	CcSEcCtD
Modafinil—Arthralgia—Temozolomide—malignant glioma	0.000359	0.00369	CcSEcCtD
Modafinil—Myalgia—Temozolomide—malignant glioma	0.000359	0.00369	CcSEcCtD
Modafinil—Anxiety—Temozolomide—malignant glioma	0.000358	0.00368	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000356	0.00366	CcSEcCtD
Modafinil—Oedema—Carmustine—malignant glioma	0.000356	0.00366	CcSEcCtD
Modafinil—Discomfort—Temozolomide—malignant glioma	0.000354	0.00364	CcSEcCtD
Modafinil—Infection—Carmustine—malignant glioma	0.000354	0.00364	CcSEcCtD
Modafinil—Dry mouth—Temozolomide—malignant glioma	0.000351	0.00361	CcSEcCtD
Modafinil—Tachycardia—Carmustine—malignant glioma	0.000347	0.00357	CcSEcCtD
Modafinil—Confusional state—Temozolomide—malignant glioma	0.000347	0.00357	CcSEcCtD
Modafinil—Oedema—Temozolomide—malignant glioma	0.000344	0.00354	CcSEcCtD
Modafinil—Anaphylactic shock—Temozolomide—malignant glioma	0.000344	0.00354	CcSEcCtD
Modafinil—Infection—Temozolomide—malignant glioma	0.000342	0.00351	CcSEcCtD
Modafinil—Anorexia—Carmustine—malignant glioma	0.000339	0.00349	CcSEcCtD
Modafinil—Nervous system disorder—Temozolomide—malignant glioma	0.000337	0.00347	CcSEcCtD
Modafinil—Skin disorder—Temozolomide—malignant glioma	0.000334	0.00343	CcSEcCtD
Modafinil—Hypotension—Carmustine—malignant glioma	0.000333	0.00342	CcSEcCtD
Modafinil—Hyperhidrosis—Temozolomide—malignant glioma	0.000332	0.00342	CcSEcCtD
Modafinil—Anorexia—Temozolomide—malignant glioma	0.000328	0.00337	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000324	0.00333	CcSEcCtD
Modafinil—Warfarin—CYP2C18—malignant glioma	0.000323	0.0541	CrCbGaD
Modafinil—Insomnia—Carmustine—malignant glioma	0.000322	0.00331	CcSEcCtD
Modafinil—Paraesthesia—Carmustine—malignant glioma	0.00032	0.00329	CcSEcCtD
Modafinil—Dyspnoea—Carmustine—malignant glioma	0.000317	0.00326	CcSEcCtD
Modafinil—Somnolence—Carmustine—malignant glioma	0.000316	0.00325	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000313	0.00322	CcSEcCtD
Modafinil—Insomnia—Temozolomide—malignant glioma	0.000311	0.0032	CcSEcCtD
Modafinil—Decreased appetite—Carmustine—malignant glioma	0.000309	0.00318	CcSEcCtD
Modafinil—Paraesthesia—Temozolomide—malignant glioma	0.000309	0.00318	CcSEcCtD
Modafinil—Gastrointestinal disorder—Carmustine—malignant glioma	0.000307	0.00316	CcSEcCtD
Modafinil—Dyspnoea—Temozolomide—malignant glioma	0.000307	0.00315	CcSEcCtD
Modafinil—Somnolence—Temozolomide—malignant glioma	0.000306	0.00314	CcSEcCtD
Modafinil—Pain—Carmustine—malignant glioma	0.000304	0.00313	CcSEcCtD
Modafinil—Constipation—Carmustine—malignant glioma	0.000304	0.00313	CcSEcCtD
Modafinil—Dyspepsia—Temozolomide—malignant glioma	0.000303	0.00311	CcSEcCtD
Modafinil—Nepafenac—PTGS1—malignant glioma	0.0003	0.0502	CrCbGaD
Modafinil—Decreased appetite—Temozolomide—malignant glioma	0.000299	0.00307	CcSEcCtD
Modafinil—Bifonazole—CYP2B6—malignant glioma	0.000299	0.05	CrCbGaD
Modafinil—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000297	0.00305	CcSEcCtD
Modafinil—Fatigue—Temozolomide—malignant glioma	0.000297	0.00305	CcSEcCtD
Modafinil—Diphenylpyraline—SLC6A3—malignant glioma	0.000294	0.0493	CrCbGaD
Modafinil—Pain—Temozolomide—malignant glioma	0.000294	0.00302	CcSEcCtD
Modafinil—Constipation—Temozolomide—malignant glioma	0.000294	0.00302	CcSEcCtD
Modafinil—Feeling abnormal—Carmustine—malignant glioma	0.000293	0.00302	CcSEcCtD
Modafinil—Gastrointestinal pain—Carmustine—malignant glioma	0.000291	0.00299	CcSEcCtD
Modafinil—Feeling abnormal—Temozolomide—malignant glioma	0.000283	0.00291	CcSEcCtD
Modafinil—Abdominal pain—Carmustine—malignant glioma	0.000281	0.00289	CcSEcCtD
Modafinil—Body temperature increased—Carmustine—malignant glioma	0.000281	0.00289	CcSEcCtD
Modafinil—Gastrointestinal pain—Temozolomide—malignant glioma	0.000281	0.00289	CcSEcCtD
Modafinil—Urticaria—Temozolomide—malignant glioma	0.000273	0.00281	CcSEcCtD
Modafinil—Body temperature increased—Temozolomide—malignant glioma	0.000272	0.0028	CcSEcCtD
Modafinil—Abdominal pain—Temozolomide—malignant glioma	0.000272	0.0028	CcSEcCtD
Modafinil—Hypersensitivity—Carmustine—malignant glioma	0.000262	0.0027	CcSEcCtD
Modafinil—Asthenia—Carmustine—malignant glioma	0.000255	0.00263	CcSEcCtD
Modafinil—Hypersensitivity—Temozolomide—malignant glioma	0.000253	0.00261	CcSEcCtD
Modafinil—Oxaprozin—PTGS1—malignant glioma	0.000249	0.0418	CrCbGaD
Modafinil—Asthenia—Temozolomide—malignant glioma	0.000247	0.00254	CcSEcCtD
Modafinil—Diarrhoea—Carmustine—malignant glioma	0.000243	0.0025	CcSEcCtD
Modafinil—Pruritus—Temozolomide—malignant glioma	0.000243	0.0025	CcSEcCtD
Modafinil—Ketoprofen—CXCL8—malignant glioma	0.000238	0.0399	CrCbGaD
Modafinil—Dizziness—Carmustine—malignant glioma	0.000235	0.00242	CcSEcCtD
Modafinil—Diarrhoea—Temozolomide—malignant glioma	0.000235	0.00242	CcSEcCtD
Modafinil—Phenytoin—CYP2C18—malignant glioma	0.000234	0.0393	CrCbGaD
Modafinil—Dizziness—Temozolomide—malignant glioma	0.000227	0.00234	CcSEcCtD
Modafinil—Vomiting—Carmustine—malignant glioma	0.000226	0.00233	CcSEcCtD
Modafinil—Benzatropine—SLC6A3—malignant glioma	0.000226	0.0378	CrCbGaD
Modafinil—Rash—Carmustine—malignant glioma	0.000224	0.00231	CcSEcCtD
Modafinil—Dermatitis—Carmustine—malignant glioma	0.000224	0.0023	CcSEcCtD
Modafinil—Headache—Carmustine—malignant glioma	0.000223	0.00229	CcSEcCtD
Modafinil—Vomiting—Temozolomide—malignant glioma	0.000219	0.00225	CcSEcCtD
Modafinil—Rash—Temozolomide—malignant glioma	0.000217	0.00223	CcSEcCtD
Modafinil—Dermatitis—Temozolomide—malignant glioma	0.000217	0.00223	CcSEcCtD
Modafinil—Headache—Temozolomide—malignant glioma	0.000215	0.00222	CcSEcCtD
Modafinil—Nausea—Carmustine—malignant glioma	0.000211	0.00217	CcSEcCtD
Modafinil—Fenoprofen—PTGS1—malignant glioma	0.000206	0.0345	CrCbGaD
Modafinil—Nausea—Temozolomide—malignant glioma	0.000204	0.0021	CcSEcCtD
Modafinil—Cinnarizine—CYP2B6—malignant glioma	0.00019	0.0318	CrCbGaD
Modafinil—Diphenhydramine—CYP2C18—malignant glioma	0.000184	0.0308	CrCbGaD
Modafinil—Carbamazepine—CYP2B6—malignant glioma	0.000179	0.03	CrCbGaD
Modafinil—Methadone—CYP2C18—malignant glioma	0.000177	0.0297	CrCbGaD
Modafinil—Phenytoin—CYP2B6—malignant glioma	0.000174	0.0291	CrCbGaD
Modafinil—Nepafenac—PTGS2—malignant glioma	0.000171	0.0287	CrCbGaD
Modafinil—Benzphetamine—CYP2B6—malignant glioma	0.00017	0.0285	CrCbGaD
Modafinil—Phenylbutazone—PTGS1—malignant glioma	0.000165	0.0276	CrCbGaD
Modafinil—Benzphetamine—SLC6A3—malignant glioma	0.000145	0.0243	CrCbGaD
Modafinil—Atomoxetine—SLC6A3—malignant glioma	0.000144	0.0241	CrCbGaD
Modafinil—Oxaprozin—PTGS2—malignant glioma	0.000143	0.0239	CrCbGaD
Modafinil—Diphenhydramine—CYP2B6—malignant glioma	0.000136	0.0228	CrCbGaD
Modafinil—Methadone—CYP2B6—malignant glioma	0.000132	0.022	CrCbGaD
Modafinil—Orphenadrine—CYP2B6—malignant glioma	0.000129	0.0216	CrCbGaD
Modafinil—Ketoprofen—PTGS1—malignant glioma	0.000122	0.0204	CrCbGaD
Modafinil—Fenoprofen—PTGS2—malignant glioma	0.000118	0.0197	CrCbGaD
Modafinil—Phenylbutazone—PTGS2—malignant glioma	9.42e-05	0.0158	CrCbGaD
Modafinil—Diphenhydramine—PTGS1—malignant glioma	8.97e-05	0.015	CrCbGaD
Modafinil—Ketoprofen—PTGS2—malignant glioma	6.95e-05	0.0116	CrCbGaD
Modafinil—ADRA1B—Signaling Pathways—GFAP—malignant glioma	1.89e-05	0.000438	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—KNG1—malignant glioma	1.87e-05	0.000434	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	1.87e-05	0.000434	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP2B6—malignant glioma	1.87e-05	0.000433	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—COX8A—malignant glioma	1.86e-05	0.00043	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ASMT—malignant glioma	1.85e-05	0.000428	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SPHK1—malignant glioma	1.83e-05	0.000424	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.8e-05	0.000419	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCR4—malignant glioma	1.79e-05	0.000415	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HEY1—malignant glioma	1.79e-05	0.000415	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—IDH1—malignant glioma	1.75e-05	0.000405	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HIST1H3B—malignant glioma	1.74e-05	0.000403	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—BCAN—malignant glioma	1.74e-05	0.000403	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—IDH1—malignant glioma	1.71e-05	0.000396	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SPHK1—malignant glioma	1.69e-05	0.000392	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CXCL8—malignant glioma	1.66e-05	0.000385	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MMP3—malignant glioma	1.66e-05	0.000385	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.66e-05	0.000385	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP2C18—malignant glioma	1.66e-05	0.000384	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SPHK1—malignant glioma	1.65e-05	0.000383	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP2C18—malignant glioma	1.62e-05	0.000375	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—JAG2—malignant glioma	1.59e-05	0.000368	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ASMT—malignant glioma	1.58e-05	0.000366	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—RAF1—malignant glioma	1.57e-05	0.000365	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.54e-05	0.000358	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—IDH2—malignant glioma	1.53e-05	0.000356	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BCAN—malignant glioma	1.48e-05	0.000344	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.45e-05	0.000336	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.44e-05	0.000335	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—COX8A—malignant glioma	1.43e-05	0.000332	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—IDH2—malignant glioma	1.4e-05	0.000325	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—H3F3A—malignant glioma	1.34e-05	0.000311	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTT1—malignant glioma	1.34e-05	0.000311	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—F2—malignant glioma	1.33e-05	0.000309	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCR3—malignant glioma	1.33e-05	0.000308	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—IDH1—malignant glioma	1.32e-05	0.000306	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.32e-05	0.000306	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.32e-05	0.000305	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTT1—malignant glioma	1.31e-05	0.000304	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NTRK2—malignant glioma	1.29e-05	0.0003	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—YWHAE—malignant glioma	1.29e-05	0.0003	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FLT1—malignant glioma	1.29e-05	0.000299	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—DUSP6—malignant glioma	1.28e-05	0.000297	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SPHK1—malignant glioma	1.28e-05	0.000296	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CG—malignant glioma	1.28e-05	0.000296	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—JAG1—malignant glioma	1.27e-05	0.000294	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOTCH3—malignant glioma	1.26e-05	0.000292	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS1—malignant glioma	1.25e-05	0.000291	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.25e-05	0.00029	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FBXW7—malignant glioma	1.24e-05	0.000288	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS1—malignant glioma	1.23e-05	0.000284	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ASMT—malignant glioma	1.22e-05	0.000282	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BDKRB2—malignant glioma	1.22e-05	0.000282	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—F2—malignant glioma	1.21e-05	0.000281	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—IDH1—malignant glioma	1.2e-05	0.000279	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—IDH2—malignant glioma	1.2e-05	0.000277	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.18e-05	0.000274	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT2—malignant glioma	1.17e-05	0.000271	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—BCHE—malignant glioma	1.17e-05	0.000271	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SPHK1—malignant glioma	1.16e-05	0.00027	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CG—malignant glioma	1.16e-05	0.000269	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.15e-05	0.000267	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BCAN—malignant glioma	1.14e-05	0.000266	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.14e-05	0.000265	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—BCHE—malignant glioma	1.14e-05	0.000264	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PTPN11—malignant glioma	1.14e-05	0.000264	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOTCH2—malignant glioma	1.13e-05	0.000262	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.13e-05	0.000261	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.13e-05	0.000261	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.12e-05	0.000261	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CD—malignant glioma	1.12e-05	0.00026	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KNG1—malignant glioma	1.11e-05	0.000257	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.08e-05	0.000249	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.07e-05	0.000249	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT2—malignant glioma	1.06e-05	0.000246	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NTRK1—malignant glioma	1.05e-05	0.000245	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.04e-05	0.000241	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—IDH1—malignant glioma	1.03e-05	0.000238	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CD—malignant glioma	1.02e-05	0.000236	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTT1—malignant glioma	1.01e-05	0.000235	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SPHK1—malignant glioma	9.95e-06	0.000231	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP3—malignant glioma	9.8e-06	0.000227	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.8e-06	0.000227	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CB—malignant glioma	9.78e-06	0.000227	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2C18—malignant glioma	9.75e-06	0.000226	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN2B—malignant glioma	9.72e-06	0.000225	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS1—malignant glioma	9.48e-06	0.00022	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.46e-06	0.000219	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.45e-06	0.000219	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTK2—malignant glioma	9.44e-06	0.000219	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CXCL8—malignant glioma	9.39e-06	0.000218	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTP1—malignant glioma	9.28e-06	0.000215	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HES1—malignant glioma	9.27e-06	0.000215	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—IDH2—malignant glioma	9.23e-06	0.000214	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTT1—malignant glioma	9.23e-06	0.000214	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NCOR1—malignant glioma	9.22e-06	0.000214	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.19e-06	0.000213	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—RAF1—malignant glioma	9.09e-06	0.000211	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTP1—malignant glioma	9.07e-06	0.00021	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CAT—malignant glioma	9.03e-06	0.000209	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—IL2—malignant glioma	8.98e-06	0.000208	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CB—malignant glioma	8.88e-06	0.000206	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CAT—malignant glioma	8.83e-06	0.000205	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PDGFRA—malignant glioma	8.83e-06	0.000205	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—BCHE—malignant glioma	8.81e-06	0.000204	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC5A5—malignant glioma	8.71e-06	0.000202	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2B6—malignant glioma	8.68e-06	0.000201	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS1—malignant glioma	8.64e-06	0.0002	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.61e-06	0.0002	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SPP1—malignant glioma	8.57e-06	0.000199	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CXCL8—malignant glioma	8.53e-06	0.000198	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NCOR1—malignant glioma	8.53e-06	0.000198	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.37e-06	0.000194	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NCOR1—malignant glioma	8.34e-06	0.000193	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.23e-06	0.000191	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.16e-06	0.000189	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL2—malignant glioma	8.15e-06	0.000189	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TERT—malignant glioma	8.12e-06	0.000188	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.08e-06	0.000187	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—BCHE—malignant glioma	8.04e-06	0.000186	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC5A5—malignant glioma	7.94e-06	0.000184	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—IDH1—malignant glioma	7.94e-06	0.000184	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PDGFB—malignant glioma	7.93e-06	0.000184	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGFR1—malignant glioma	7.89e-06	0.000183	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTT1—malignant glioma	7.88e-06	0.000183	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HIF1A—malignant glioma	7.77e-06	0.00018	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SPHK1—malignant glioma	7.68e-06	0.000178	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.52e-06	0.000174	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CAV1—malignant glioma	7.51e-06	0.000174	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.51e-06	0.000174	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.44e-06	0.000173	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KDR—malignant glioma	7.43e-06	0.000172	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS1—malignant glioma	7.39e-06	0.000171	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.36e-06	0.000171	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—F2—malignant glioma	7.15e-06	0.000166	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FN1—malignant glioma	7.15e-06	0.000166	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.11e-06	0.000165	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BAD—malignant glioma	7.07e-06	0.000164	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTP1—malignant glioma	7.01e-06	0.000163	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOTCH1—malignant glioma	7e-06	0.000162	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CAV1—malignant glioma	6.95e-06	0.000161	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BCHE—malignant glioma	6.87e-06	0.000159	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CD80—malignant glioma	6.86e-06	0.000159	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CG—malignant glioma	6.84e-06	0.000159	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APC—malignant glioma	6.84e-06	0.000159	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CAT—malignant glioma	6.82e-06	0.000158	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CAV1—malignant glioma	6.8e-06	0.000158	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC5A5—malignant glioma	6.78e-06	0.000157	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGF—malignant glioma	6.76e-06	0.000157	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTPN11—malignant glioma	6.72e-06	0.000156	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.49e-06	0.00015	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NCOR1—malignant glioma	6.44e-06	0.000149	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BRAF—malignant glioma	6.43e-06	0.000149	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.42e-06	0.000149	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTP1—malignant glioma	6.39e-06	0.000148	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.36e-06	0.000147	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CG—malignant glioma	6.33e-06	0.000147	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT2—malignant glioma	6.26e-06	0.000145	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EGFR—malignant glioma	6.23e-06	0.000145	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CAT—malignant glioma	6.22e-06	0.000144	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CG—malignant glioma	6.19e-06	0.000144	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARG—malignant glioma	6.11e-06	0.000142	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTT1—malignant glioma	6.08e-06	0.000141	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CD—malignant glioma	6.02e-06	0.00014	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARG—malignant glioma	5.97e-06	0.000139	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CA—malignant glioma	5.96e-06	0.000138	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—KRAS—malignant glioma	5.89e-06	0.000137	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NCOR1—malignant glioma	5.88e-06	0.000136	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGF2—malignant glioma	5.76e-06	0.000134	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS1—malignant glioma	5.7e-06	0.000132	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CD—malignant glioma	5.57e-06	0.000129	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.54e-06	0.000129	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTP1—malignant glioma	5.46e-06	0.000127	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CD—malignant glioma	5.44e-06	0.000126	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	5.41e-06	0.000125	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MDM2—malignant glioma	5.39e-06	0.000125	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RAF1—malignant glioma	5.37e-06	0.000125	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CAT—malignant glioma	5.32e-06	0.000123	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	5.31e-06	0.000123	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BCHE—malignant glioma	5.3e-06	0.000123	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CAV1—malignant glioma	5.25e-06	0.000122	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	5.24e-06	0.000122	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.24e-06	0.000121	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	5.04e-06	0.000117	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NCOR1—malignant glioma	5.02e-06	0.000116	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.02e-06	0.000116	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	4.87e-06	0.000113	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CB—malignant glioma	4.85e-06	0.000113	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CASP3—malignant glioma	4.82e-06	0.000112	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—malignant glioma	4.82e-06	0.000112	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—malignant glioma	4.81e-06	0.000112	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CAV1—malignant glioma	4.79e-06	0.000111	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CG—malignant glioma	4.79e-06	0.000111	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CB—malignant glioma	4.74e-06	0.00011	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—malignant glioma	4.7e-06	0.000109	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARG—malignant glioma	4.62e-06	0.000107	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.58e-06	0.000106	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—malignant glioma	4.56e-06	0.000106	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTEN—malignant glioma	4.53e-06	0.000105	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	4.42e-06	0.000103	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.36e-06	0.000101	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTP1—malignant glioma	4.22e-06	9.78e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARG—malignant glioma	4.21e-06	9.77e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.21e-06	9.76e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTEN—malignant glioma	4.19e-06	9.72e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CAT—malignant glioma	4.1e-06	9.52e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTEN—malignant glioma	4.1e-06	9.5e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CAV1—malignant glioma	4.09e-06	9.49e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	4.09e-06	9.49e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—malignant glioma	4.05e-06	9.4e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.91e-06	9.07e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NCOR1—malignant glioma	3.88e-06	8.99e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.84e-06	8.9e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—malignant glioma	3.77e-06	8.73e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.73e-06	8.65e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGFR—malignant glioma	3.68e-06	8.54e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.67e-06	8.5e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—malignant glioma	3.63e-06	8.43e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARG—malignant glioma	3.6e-06	8.35e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KRAS—malignant glioma	3.48e-06	8.07e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.34e-06	7.75e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—malignant glioma	3.31e-06	7.68e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.28e-06	7.6e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	3.2e-06	7.41e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTEN—malignant glioma	3.17e-06	7.35e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CAV1—malignant glioma	3.16e-06	7.33e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—malignant glioma	3.09e-06	7.17e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.96e-06	6.86e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.89e-06	6.71e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTEN—malignant glioma	2.89e-06	6.7e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.88e-06	6.67e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.86e-06	6.63e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—malignant glioma	2.83e-06	6.57e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARG—malignant glioma	2.78e-06	6.44e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—malignant glioma	2.61e-06	6.06e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.53e-06	5.87e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTEN—malignant glioma	2.47e-06	5.73e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—malignant glioma	2.42e-06	5.6e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—malignant glioma	2.36e-06	5.48e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.24e-06	5.18e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.21e-06	5.11e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—malignant glioma	2.18e-06	5.07e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.04e-06	4.73e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTEN—malignant glioma	1.91e-06	4.42e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—malignant glioma	1.83e-06	4.23e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.74e-06	4.04e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—malignant glioma	1.67e-06	3.86e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—malignant glioma	1.42e-06	3.3e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.34e-06	3.12e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—malignant glioma	1.1e-06	2.55e-05	CbGpPWpGaD
